Clinical Trial Update: "Treatment of Active HBV With γδT Cells" Clinical Trial Protocol [EARLY_Phase 1]

View source ↗

Summary

This clinical trial protocol describes an early-phase (Phase 1) study to treat active hepatitis B using adoptive γδ T cell therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• T-cell therapy

Snippet

Sponsor: Jinan University Guangzhou | Conditions: Adoptive Treatment for Hepatitis B With γδT Cells | EARLY_Phase 1 | Status: UNKNOWN